Within this section of the website, you will find patient information regarding our licensed products. These information sources include patient information leaflets, the summary of product characteristics and European Public Assessment Reports.
- The patient information leaflets (PILs) provide important information for patients taking our licensed products.
- The summary of product characteristics (SmPC) is a description of a medicinal product including recommendations for its use.
- The European Public Assessment Report (EPAR) explains how the Committee for Medicinal products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine.
Please note that this information is specific to the UK and is not intended to replace the advice of a qualified doctor or pharmacist.